Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the impact of participant care and support on
treatment adherence. PegIntron pen and Rebetol will be administered to participants with
Hepatitis C Virus (HCV) in accordance with approved labeling. Sites will be categorized as
providing high vs low level of participant management based on information about the level of
participant support and management captured on the site questionnaire. Data on each
participant will be collected by a physician on an electronic participant case report form
(CRF) and by the participant via a questionnaire. Treatment completion rates will be analyzed
based on the high vs low level of participant management.
The hypothesis is that Physicians investing more time and effort into participant management
achieve higher treatment completion rates among their hepatitis C patients than physicians
offering less participant management measures.